Yap signalling regulates ductular reactions in mice with CRISPR/Cas9-induced glycogen storage disease type Ia

References

• Bai HB, Zhang NL, Xu Y, Chen Q, Khan M, Potter JJ, Nayar SK, Cornish T, Alpini G, Bronk S, et al. 2012. Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology. 56:1097–1107.
   PubMed Web of Science ®Google Scholar
• Capecchi MR. 1989. The new mouse genetics: altering the genome by gene targeting. Trends Genet. 5:70–76.
   PubMed Web of Science ®Google Scholar
• Chao W, Zhu X, Feng W, Yu Y, Mills GB. 2015. Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm. Am J Cancer Res. 6:27–37.
   PubMed Web of Science ®Google Scholar
• Dong L, Lin F, Wu W, Liu Y, Huang W. 2018. Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via hippo signaling pathway. Intern J Med Sci. 15:645–652.
   PubMed Web of Science ®Google Scholar
• Driskill JH, Pan DJ. 2021. The hippo pathway in liver homeostasis and pathophysiology. In: Annual review of pathology: mechanisms of disease, Vol. 16, 2021. Palo Alto: Annual Reviews. p. 299–322.
   Google Scholar
• Gadd VL, Skoien R, Powell EE, Fagan KJ, Winterford C, Horsfall L, Irvine K, Clouston AD. 2014. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology. 59(4):1393-1405.
   Web of Science ®Google Scholar
• Gavini J, Dommann N, Jakob MO, Keogh A, Banz V. 2019. Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma. Cell Death Dis. 10:1–17.
   Web of Science ®Google Scholar
• Gurda GT, Zhu Q, Bai H, Pan D, Schwarz KB, Anders RA. 2014. The use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease. Hum Pathol. 45:1057–1064.
   PubMed Web of Science ®Google Scholar
• Han X, Wang Y, Pu W, Huang X, Qiu L, Li Y, Yu W, Zhao H, Liu X, He L. 2019. Lineage tracing reveals the bipotency of SOX9+ hepatocytes during liver regeneration. Stem Cell Rep.12(3): 624-638.
   Google Scholar
• Hwang WY, Fu YF, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JRJ, Joung JK. 2013. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol. 31:227–229.
   PubMed Web of Science ®Google Scholar
• Jin LF, Huang HR, Ni J, Shen JY, Liu ZP, Li LJ, Fu SM, Yan JY, Hu BW. 2021. Shh-Yapsignaling controls hepatic ductular reactions inCCl(4)-induced liver injury. Environ Toxicol. 36:194–203.
   PubMed Web of Science ®Google Scholar
• Jörs S, Jeliazkova P, Ringelhan M, Thalhammer J, Geisler F. 2015. Lineage fate of ductular reactions in liver injury and carcinogenesis. J Clin Investig. 125:2445–2457.
   PubMed Web of Science ®Google Scholar
• Kele PG, van der Jagt EJ, Gouw ASH, Lisman T, Porte RJ, de Boer MT. 2013. The impact of hepatic steatosis on liver regeneration after partial hepatectomy. Liver Int. 33:469–475.
   PubMed Web of Science ®Google Scholar
• Kishnani PS, Austin SL, Abdenur JE, Arn P, Watson MS. 2014. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics. Genet Med Off J Amer Coll Med Genet. 16:e1.
   Google Scholar
• Kishnani PS, Faulkner E, VanCamp S, Jackson M, Brown T, Boney A, Koeberl D, Chen Y-T. 2001. Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia). Vet Pathol. 38:83–91.
   PubMed Web of Science ®Google Scholar
• Lei KJ, Chen H, Pan CJ, Ward JM, Mosinger B, Lee EJ, Westphal H, Mansfield BC, Chou JY. 1996. Glucose–6–phosphatase dependent substrate transport in the glycogen storage disease type–1a mouse. Nat Genet. 13:203–209.
   PubMed Web of Science ®Google Scholar
• Lei KJ, Pan CJ, Shelly LL, Liu JL, Chou JY. 1994. Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. J Clin Investig. 93:1994–1999.
   PubMed Web of Science ®Google Scholar
• Lu L, Finegold MJ, Johnson RL. 2018. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Exper Mol Med. 50:e423.
   PubMed Web of Science ®Google Scholar
• Lu YL, Wang LY, Li J, Wu BB, Wu HP, Luo Y, Jin ZB, Shan XO. 2016. Molecular genetic analysis and phenotypic characteristics of a consanguineous family with glycogen storage disease type Ia. Mol Med Rep. 14:3251–3254.
   PubMed Web of Science ®Google Scholar
• Monteillet L, Gjorgjieva M, Silva M, Verzieux V, Imikirene L, Duchampt A, Guillou H, Mithieux G, Rajas F. 2018. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context. Mol Metab. 16:100–115.
   PubMed Web of Science ®Google Scholar
• Mutel E, Abdul-Wahed A, Ramamonjisoa N, Stefanutti A, Houberdon I, Cavassila S, Pilleul F, Beuf O, Gautier-Stein A, Penhoat A. 2011. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas. J Hepatol. 54:0–537.
   Web of Science ®Google Scholar
• Nguyen-Lefebvre AT, Selzner N, Wrana JL, Bhat M. 2021. The hippo pathway: A master regulator of liver metabolism, regeneration, and disease. Faseb J. May. 35:25.
   Web of Science ®Google Scholar
• Peng WT, Pan CJ, Lee EJ, Westphal H, Chou JY. 2009. Generation of mice With a conditional allele for G6pc. Gen Sep. 47:590–594.
   Google Scholar
• Planas-Paz L, Sun T, Pikiolek M, Cochran NR, Tchorz JS. 2019. YAP, but Not RSPO-LGR4/5, signaling in biliary epithelial cells promotes a ductular reaction in response to liver injury. Cell Stem Cell. 25:39-53.
   Web of Science ®Google Scholar
• Qiu SQ, Vazquez JT, Boulger E, Liu HY, Xue P, Hussain MA, Wolfe A. 2017. Hepatic estrogen receptor alpha is critical for regulation of gluconeogenesis and lipid metabolism in males. Sci Rep. 10:7.
   Google Scholar
• Quan Y, Li Z, Zhu KS, Liang JD. 2021. Transcatheter arterial chemoembolization combined with Hippo/YAP inhibition significantly improve the survival of rats with transplanted hepatocellular carcinoma. Lipids Health Dis. 25:20.
   Google Scholar
• Resaz R, Rosa F, Grillo F, Basso L, Segalerba D, Puglisi A, Busco MC, Mastracci L, Neumaier CE, Varesio L, et al. 2019. Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A. Dis Model Mech. 12(4):11923.
   Web of Science ®Google Scholar
• Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander–Tetri B, Bhathal PS, Dixon JB, Weltman M, Tilg H, Moschen AR. 2007. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology. 133:80–90.
   PubMed Web of Science ®Google Scholar
• Sato K, Marzioni M, Meng F, Francis H, Glaser S, Alpini G. 2019a. Ductular reaction in liver diseases: pathological mechanisms and translational significances (vol. 69, pg 420, 2019). Hepatology. 70:1089–1089.
   PubMed Web of Science ®Google Scholar
• Sato K, Marzioni M, Meng FY, Francis H, Glaser S, Alpini G. 2019b. Ductular reaction in liver diseases: pathological mechanisms and translational significances. Hepatology. 69:420–430.
   PubMed Web of Science ®Google Scholar
• Shieh JJ, Terzioglu M, Hiraiwa H, Marsh J, Pan CJ, Chen LY, Chou JY. 2002. The molecular basis of glycogen storage disease type 1a: structure and function analysis of mutations in glucose-6-phosphatase. J Biol Chem. 277:5047–5053.
   PubMedGoogle Scholar
• Skoien R, Richardson MM, Jonsson JR, Powell EE, Louston AC. 2013. Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. Liver Int. 33:624–632.
   PubMed Web of Science ®Google Scholar
• Song K, Kwon H, Han C, Chen W, Zhang J, Ma W, Dash S, Gandhi CR, Wu T. 2020. Yes-associated protein in Kupffer cells enhances the production of proinflammatory cytokines and promotes the development of nonalcoholic steatohepatitis. Hepatology. 72(1):72–8772.
   PubMed Web of Science ®Google Scholar
• Sun TL, Annunziato S, Tchorz JS. 2019. Hepatic ductular reaction: a double-edged sword. Aging-US. 15(11):9223–9224.
   Google Scholar
• Udawat P, Shah R, Karthi S, Dhir V. 2019. A novel mutations in the glucose-6-phosphatase gene in heterozygous state that cause glycogen storage disease type 1a. J Gastroen Hepatol. 34:758–758.
   Web of Science ®Google Scholar
• Wang C, Zhu XY, Feng WW, Yu YH, Jeong KJ, Guo W, Lu YL, Mills GB. 2016. Verteporfin inhibits YAP function through up-regulating 14-3-3 sigma sequestering YAP in the cytoplasm. Amer J Cancer Res. 6:27–37.
   PubMed Web of Science ®Google Scholar
• Wang HY, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. 2013. One-Step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 9(153):910–918.
   Google Scholar
• Wang J, Cui H, Lee NC, Hwu WL, Chien YH, Craigen WJ, Wong LJ, Zhang VW. 2013. Clinical application of massively parallel sequencing in the molecular diagnosis of glycogen storage diseases of genetically heterogeneous origin. Genet Med. 15:106–114.
   PubMed Web of Science ®Google Scholar
• Wang LB, Li MY, Qu C, Miao WY, Yin Q, Liao JY, Cao HT, Huang M, Wang K, Zuo EW, et al. 2017. CRISPR-Cas9-mediated genome editing in one blastomere of two-cell embryos reveals a novel Tet3 function in regulating neocortical development. Cell Res. 27:815–829.
   PubMed Web of Science ®Google Scholar
• Williams MJ, Clouston AD, Forbes SJ. 2014. Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology. 146:349–356.
   PubMed Web of Science ®Google Scholar
• Yan JY, Huang HR, Liu ZP, Shen JY, Ni J, Han JW, Wang RJ, Lin DR, Hu BW, Jin LF. 2020. Hedgehog signaling pathway regulates hexavalent chromium-induced liver fibrosis by activation of hepatic stellate cells. Toxicol Lett. 320:1–8.
   PubMed Web of Science ®Google Scholar
• Yen ST, Zhang M, Deng JM, Usman SJ, Smith CN, Parker-Thornburg J, Swinton PG, Martin JF, Behringer RR. 2014. Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes. Dev Biol. 393:3–9.
   PubMed Web of Science ®Google Scholar
• Zhang BQ, Zeng XJ. 2016. Tophaceous gout in a female premenopausal patient with an unexpected diagnosis of glycogen storage disease type Ia: a case report and literature review. Clin Rheumatol. 35:2851–2856.
   PubMed Web of Science ®Google Scholar
• Zhang N, Bai H, David KK, Dong J, Zheng Y, Jing C, Giovannini M, Liu P, Anders RA, Pan D. 2010. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Develop Cell. 19:27–38.
   PubMed Web of Science ®Google Scholar
• Zhenxue T, Qingxia M, Luyao W, Chaolong L, Hui G. 2019. A brief review: some compounds targeting YAP against malignancies. Fut Oncol (London, England). 15(13):1535–1543.
   PubMed Web of Science ®Google Scholar
• Zhou H, Rogler LE, Teperman L, Morgan G, Rogler CE. 2007. Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology. 45(3):716–724.
   PubMed Web of Science ®Google Scholar